Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-021-05428-7
Abstract: We thank Dr. Campaña and Dr. Bernal for their interest in our recent study about the prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI with diffusionweighted imaging (DWI) and contrast-enhanced CT in primary nodal staging of… read more here.
Keywords: psma; 18f psma; prostate cancer; psma 1007 ... See more keywords
[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients
Sign Up to like & getrecommendations! Published in 2025 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-025-07085-6
Abstract: We hypothesised that applying radiomics to [18F]PSMA-1007 PET/CT images could help distinguish Unspecific Bone Uptakes (UBUs) from bone metastases in prostate cancer (PCa) patients. We compared the performance of radiomic features to human visual interpretation.… read more here.
Keywords: psma 1007; 18f psma; prostate cancer; bone ... See more keywords
The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Nuclear Medicine"
DOI: 10.1007/s12149-025-02026-7
Abstract: This study aimed the role of volumetric and dissemination features of staging [18F]PSMA-1007 PET/CT in predicting progression‐free survival (PFS) in patients with prostate cancer (PCa) and their relationship with the main clinical data (ISUP grade… read more here.
Keywords: psma 1007; volumetric dissemination; 18f psma; psma ... See more keywords
Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00788
Abstract: Several radiolabeled prostate-specific membrane antigen (PSMA)-targeted agents have been developed for detecting prostate cancer, using positron emission tomography imaging and targeted radionuclide therapy. Among them, [18F]PSMA-1007 has several advantages, including a comparatively long half-life, delayed… read more here.
Keywords: prostate cancer; psma; psma 1007; 18f psma ... See more keywords
The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone
Sign Up to like & getrecommendations! Published in 2024 at "British Journal of Cancer"
DOI: 10.1038/s41416-024-02934-x
Abstract: The diagnostic utility of prostate biopsy is limited for prostate cancer (PCa) in the prostate-specific antigen (PSA) grey zone. This study aims to evaluate the diagnostic performance of multiparametric magnetic resonance imaging (mpMRI) and prostate-specific… read more here.
Keywords: psma 1007; 18f psma; prostate; pet ... See more keywords
[18F]-PSMA-1007 PET imaging optimization and inter-rater reliability – a comparison of three different reconstructions read by four radiologists
Sign Up to like & getrecommendations! Published in 2024 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001823
Abstract: Objectives To increase understanding of optimal imaging parameters [18F]PSMA-1007 when imaging patients with prostate cancer and to determine interrater agreement using [18F]PSMA-1007. Methods In this observational study, four independent physicians read reconstruction sets using bedtimes… read more here.
Keywords: psma 1007; 18f psma; rater reliability;
Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002354
Abstract: Prostate-specific membrane antigen (PSMA) is a membrane glycoprotein that is overexpressed in prostate cancer cells. It is also expressed in other normal tissues and several other malignant and benign diseases. We present a case of… read more here.
Keywords: psma 1007; prostate cancer; psma; 1007 pet ... See more keywords
A Comparison of 18F-PSMA-1007 and 64Cu-PSMA in 2 Patients With Metastatic Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000003758
Abstract: ABSTRACT 18F-prostate-specific membrane antigen (PSMA) 1007 is one of the most promising radiotracers for PET imaging in prostate cancer, minimal urinary clearance, and higher spatial resolution, which are the most outstanding features. PSMA can also… read more here.
Keywords: psma 1007; psma; metastatic prostate; prostate cancer ... See more keywords
Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004013
Abstract: ABSTRACT Two women were referred for an 18F-PSMA-1007 PET/CT in follow-up of an adenoid cystic tumor of the subglottic region and the bronchus, respectively. Only limited tracer uptake was seen in the region of local… read more here.
Keywords: psma 1007; 18f psma; pet; corpus luteum ... See more keywords
Comparison of Internal Dosimetry of 18F-PSMA-1007 and 68Ga-PSMA-11-HBED-CC
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004353
Abstract: Background Prostate cancer (PCa) is the most common cancer in men worldwide. Targeting prostate-specific membrane antigen (PSMA) using radiopharmaceuticals has shown promising results for PCa imaging as well as theranostics. 68Ga-based PSMA imaging is limited… read more here.
Keywords: mgy mbq; psma hbed; 68ga psma; psma ... See more keywords
Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004430
Abstract: Purpose This study aimed to compare 18F-PSMA-1007 PET/CT with 68Ga-PSMA-11 PET/CT for initial staging in intermediate- and high-risk prostate cancer (PCa) patients. Methods Forty treatment-naive, biopsy-proven, intermediate- or high-risk PCa patients were prospectively recruited. Each… read more here.
Keywords: pet; 68ga psma; psma; 1007 pet ... See more keywords